Auditor Resigns at Micro-Cap OSR Health, Citing Unpaid 2025 Audit Fees
OSRH sits 59% above its 52-week low of $0.075.
Summary
Shinhan Accounting Corporation resigned as OSR Health's independent auditor on Nov 6, 2026, and said overdue fees for the 2025 audit threatened its independence. An auditor walking over unpaid bills is a red flag: it points to a cash squeeze and raises the odds the 2025 audit opinion is delayed or qualified. The company already disclosed unremediated material weaknesses and ineffective disclosure controls in its Q2 2026 10-Q, with only $1.5 million in cash and a 72% revenue decline. This lands after the August Nasdaq delisting determination and the company's hearing request, so the listing is already on the clock. A replacement auditor must be engaged and the 2025 audit completed for OSRH to keep its reporting current.
At the time of this announcement, OSRH was trading at $0.12 on OTC in the Life Sciences sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $0.08 to $0.90. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.